Evidence map›Paper›PMID 32968075›Full record

ArticleNature communications2020

Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR.

Ioanna Smyrlaki, Martin Ekman, Antonio Lentini, Nuno Rufino de Sousa, Natali Papanicolaou, Martin Vondracek, Johan Aarum, Hamzah Safari, Shaman Muradrasoli, Antonio Gigliotti Rothfuchs and 3 more

Open access · goldAbstract readComparative StudyEvaluation StudyValidation Study
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 255 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
255citing papers in PubMed, 3 pooled it
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

255 citing papers in PubMed, 3 syntheses or guidelines pooled it, 473 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Towards deployable CRISPR-based nucleic acid detection.Progress in biomedical engineering (Bristol, England) · 2026
    Review
  9. Simultaneous detection of SARS-CoV-2 proteins and nucleic acids by coupling PNIPAM with circle-to-circle amplification.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  10. Article
  11. Article
  12. Development of a Platform forAerosol science and technology : the journal of the American Association for Aerosol Research · 2026
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. A review on the mechanism and potential diagnostic application of CRISPR/Cas13a system.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Review
  19. Article
  20. Article

195 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ioanna Smyrlaki *Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.
Martin Ekman *Department of Clinical Microbiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Antonio LentiniDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1239-5495
Nuno Rufino de SousaDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-0670-9788
Natali PapanicolaouDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.
Martin VondracekDepartment of Clinical Microbiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Johan AarumDepartment of Clinical Microbiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Hamzah SafariDepartment of Clinical Microbiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.
Shaman MuradrasoliPublic Health Agency of Sweden, 171 82, Solna, Sweden.
Antonio Gigliotti RothfuchsDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-6001-7240
Jan AlbertDepartment of Clinical Microbiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-9020-0521
Björn HögbergDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2715-7887
Björn ReiniusDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden. bjorn.reinius@ki.se.ORCID http://orcid.org/0000-0002-7021-5248
Karolinska Institutet · SEKarolinska University Hospital · SEPublic Health Agency of Sweden · SE

Funding

Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) 2020.0182Ragnar Söderbergs stiftelse (Ragnar Söderberg Foundation) M16/17Science for Life Laboratory (SciLifeLab) 2020.0182Vetenskapsrådet (Swedish Research Council) 2017-01723
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is commonly diagnosed by reverse transcription polymerase chain reaction (RT-PCR) to detect viral RNA in patient samples, but RNA extraction constitutes a major bottleneck in current testing. Methodological simplification could increase diagnostic availability and efficiency, benefitting patient care and infection control. Here, we describe methods circumventing RNA extraction in COVID-19 testing by performing RT-PCR directly on heat-inactivated or lysed samples. Our data, including benchmarking using 597 clinical patient samples and a standardised diagnostic system, demonstrate that direct RT-PCR is viable option to extraction-based tests. Using controlled amounts of active SARS-CoV-2, we confirm effectiveness of heat inactivation by plaque assay and evaluate various generic buffers as transport medium for direct RT-PCR. Significant savings in time and cost are achieved through RNA-extraction-free protocols that are directly compatible with established PCR-based testing pipelines. This could aid expansion of COVID-19 testing.

Indexed as

BenchmarkingBetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingDNA PrimersHot TemperatureHumansPandemicsPneumonia, ViralReverse Transcriptase Polymerase Chain ReactionRNA, ViralSARS-CoV-2Sensitivity and SpecificitySwedenDNA PrimersRNA, Viral

Identifiers

PMID32968075
PMCPMC7511968
OpenAlexW3088011310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.